Detalhe da pesquisa
1.
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.
Crit Care Med
; 41(9): 2069-79, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23979365